---
title: "Skye Bioscience, Inc. (SKYE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SKYE.US.md"
symbol: "SKYE.US"
name: "Skye Bioscience, Inc."
industry: "生物技术"
---

# Skye Bioscience, Inc. (SKYE.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [kyebioscience.com](https://kyebioscience.com) |

## Company Profile

Skye Bioscience, Inc.是一家临床阶段的生物制药公司，专注于开发调节 G 蛋白偶联受体（GPCRs）的分子，以治疗肥胖、超重和代谢疾病。其主要产品候选药物是 nimacimab，这是一种外周限制的负变构调节抗体，靶向大麻素受体 1，这是一个在代谢调节中起关键作用的 GPCR。该公司之前名为 Emerald Bioscience, Inc.，并更名为 Skye Bioscience, Inc

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.48 | 139/602 | - | - | - |
| PB | 0.75 | 57/602 | 2.06 | 1.08 | 0.87 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-03T05:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 50% |
| Overweight | 2 | 25% |
| Hold | 2 | 25% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.77 |
| Highest Target | 20.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SKYE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SKYE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SKYE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.